Ligand Regulation Strategy to Modulate ROS Nature in a Rhodamine-Iridium(III) Hybrid System for Phototherapy
Inorganic Chemistry · 2024
DOI: 10.1021/acs.inorgchem.3c04350 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2024. Verfasst von Fangfang Wei und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Photosensitizing Agents, Photochemotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 83 Literaturangaben. Gefördert von: Guangdong Provincial Department of Science and Technology, Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
The efficacy of photodynamic therapy (PDT) is highly dependent on the photosensitizer features. The reactive oxygen species (ROS) generated by photosensitizers is proven to be associated with immunotherapy by triggering immunogenic cell death (ICD) as well. In this work, we establish a rhodamine-iridium(III) hybrid model functioning as a photosensitizer to comprehensively understand its performance and potential applications in photodynamic immunotherapy. Especially, the correlation between the ROS generation efficiency and the energy level of the Ir(III)-based excited state (T1'), modulated by the cyclometalating (C∧N) ligand, is systematically investigated and correlated. We prove that in addition to the direct population of the rhodamine triplet state (T1) formed through the intersystem crossing process with the assistance of a heavy Ir(III) metal center, the fine-tuned T1' state could act as a relay to provide an additional pathway for promoting the cascade energy transfer process that leads to enhanced ROS generation ability. Moreover, type I ROS can be effectively produced by introducing sulfur-containing thiophene units in C∧N ligands, providing a stronger M1 macrophage-activation efficiency under hypoxia to evoke in vivo antitumor immunity. Overall, our work provides a fundamental guideline for the molecular design and exploration of advanced transition-metal-based photosensitizers for biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Southern University of Science and Technology, Shenzhen 518055, China.
- Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China.
- Department of Chemistry, Hong Kong Baptist University, Kowloon Tong, Hong Kong S.A.R., China.
ORCID-Profile: Ka-Leung Wong, Kai Li, Keith Man-Chung Wong
Förderung
- Guangdong Provincial Department of Science and Technology
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- National Science and Technology Major Project
- Guangdong Provincial Key Laboratory of Advanced Biomaterials
Zitieren
APA
Wei, F., Chen, F., Wu, S., Zha, M., Liu, J., Wong, K. L., Li, K., & Wong, K. M. (2024). Ligand Regulation Strategy to Modulate ROS Nature in a Rhodamine-Iridium(III) Hybrid System for Phototherapy. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.3c04350
Vancouver
Wei F, Chen F, Wu S, Zha M, Liu J, Wong KL, et al. Ligand Regulation Strategy to Modulate ROS Nature in a Rhodamine-Iridium(III) Hybrid System for Phototherapy. Inorganic Chemistry. 2024. doi:10.1021/acs.inorgchem.3c04350
BibTeX
@article{Wei2024,
author = {Wei, Fangfang and Chen, Feng and Wu, Siye and Zha, Menglei and Liu, Jiqiang and Wong, Ka-Leung and Li, Kai and Wong, Keith Man-Chung},
title = {Ligand Regulation Strategy to Modulate ROS Nature in a Rhodamine-Iridium(III) Hybrid System for Phototherapy},
journal = {Inorganic Chemistry},
year = {2024},
doi = {10.1021/acs.inorgchem.3c04350}
}
EUVIMED